The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Bioasis Technologies - Technology for Delivery of Therapeutics Across the Blood-Brain Barrier Discusses Target Indications and Growth Drivers for 2019

SNNLive spoke with Mark Day, Ph.D., President & CEO of Bioasis Technologies Inc. (OTCQB: BIOAF) (TSX-V: BTI) at the BIO CEO & Investor Conference 2019 in New York, NY.

Share With

Tuesday, March 05, 2019

   

© 2019 Stock News Now